Free Trial

Impax Asset Management Group plc Has $41.22 Million Stake in Procter & Gamble Company (The) (NYSE:PG)

Procter & Gamble logo with Consumer Staples background

Impax Asset Management Group plc cut its stake in shares of Procter & Gamble Company (The) (NYSE:PG - Free Report) by 19.3% in the 1st quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 241,842 shares of the company's stock after selling 57,740 shares during the quarter. Impax Asset Management Group plc's holdings in Procter & Gamble were worth $41,215,000 as of its most recent SEC filing.

Several other institutional investors also recently made changes to their positions in PG. Navigoe LLC bought a new position in shares of Procter & Gamble during the fourth quarter valued at approximately $31,000. Capital A Wealth Management LLC bought a new position in Procter & Gamble in the 4th quarter worth approximately $31,000. Hoey Investments Inc. grew its holdings in Procter & Gamble by 321.7% in the 4th quarter. Hoey Investments Inc. now owns 194 shares of the company's stock worth $33,000 after buying an additional 148 shares in the last quarter. LFA Lugano Financial Advisors SA bought a new position in Procter & Gamble in the 4th quarter worth approximately $34,000. Finally, 10Elms LLP bought a new position in Procter & Gamble in the 4th quarter worth approximately $34,000. 65.77% of the stock is owned by institutional investors.

Procter & Gamble Price Performance

Shares of NYSE:PG traded down $0.48 on Friday, reaching $160.72. 6,999,589 shares of the company traded hands, compared to its average volume of 7,494,586. The company's 50 day moving average is $162.10 and its 200-day moving average is $165.30. The stock has a market capitalization of $376.82 billion, a PE ratio of 25.51, a P/E/G ratio of 4.58 and a beta of 0.40. Procter & Gamble Company has a fifty-two week low of $156.58 and a fifty-two week high of $180.43. The company has a debt-to-equity ratio of 0.47, a current ratio of 0.71 and a quick ratio of 0.50.

Procter & Gamble (NYSE:PG - Get Free Report) last released its earnings results on Thursday, April 24th. The company reported $1.54 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of $1.53 by $0.01. The company had revenue of $19.78 billion during the quarter, compared to analyst estimates of $20.42 billion. Procter & Gamble had a return on equity of 32.67% and a net margin of 18.46%. The company's revenue for the quarter was down 2.1% on a year-over-year basis. During the same quarter in the prior year, the company earned $1.52 earnings per share. As a group, analysts anticipate that Procter & Gamble Company will post 6.91 earnings per share for the current fiscal year.

Procter & Gamble Increases Dividend

The firm also recently announced a quarterly dividend, which was paid on Thursday, May 15th. Stockholders of record on Monday, April 21st were issued a $1.0568 dividend. The ex-dividend date was Monday, April 21st. This represents a $4.23 dividend on an annualized basis and a dividend yield of 2.63%. This is a positive change from Procter & Gamble's previous quarterly dividend of $1.01. Procter & Gamble's dividend payout ratio is presently 67.14%.

Wall Street Analyst Weigh In

A number of equities analysts recently issued reports on PG shares. Redburn Partners set a $161.00 price objective on Procter & Gamble in a report on Thursday, May 1st. Evercore ISI reissued an "outperform" rating and issued a $190.00 price objective (up from $170.00) on shares of Procter & Gamble in a report on Tuesday, June 3rd. Morgan Stanley set a $180.00 price objective on Procter & Gamble and gave the stock an "overweight" rating in a report on Friday, April 25th. Barclays reissued an "equal weight" rating on shares of Procter & Gamble in a report on Thursday, March 27th. Finally, Truist Financial decreased their price target on Procter & Gamble from $185.00 to $180.00 and set a "buy" rating for the company in a research note on Friday, April 25th. Eight research analysts have rated the stock with a hold rating, fourteen have issued a buy rating and two have issued a strong buy rating to the company's stock. According to MarketBeat, the stock has an average rating of "Moderate Buy" and a consensus price target of $178.45.

View Our Latest Report on PG

Insiders Place Their Bets

In other news, insider Moses Victor Javier Aguilar sold 10,520 shares of the company's stock in a transaction on Monday, May 5th. The shares were sold at an average price of $158.67, for a total value of $1,669,208.40. Following the transaction, the insider directly owned 25,182 shares of the company's stock, valued at approximately $3,995,627.94. This represents a 29.47% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which can be accessed through this link. Also, CEO Jennifer L. Davis sold 1,000 shares of the company's stock in a transaction on Tuesday, April 29th. The stock was sold at an average price of $161.38, for a total transaction of $161,380.00. Following the completion of the transaction, the chief executive officer directly owned 51,965 shares in the company, valued at $8,386,111.70. This trade represents a 1.89% decrease in their ownership of the stock. The disclosure for this sale can be found here. Corporate insiders own 0.18% of the company's stock.

About Procter & Gamble

(Free Report)

Procter & Gamble Co engages in the provision of branded consumer packaged goods. It operates through the following segments: Beauty, Grooming, Health Care, Fabric and Home Care, and Baby, Feminine and Family Care. The Beauty segment offers hair, skin, and personal care. The Grooming segment consists of shave care like female and male blades and razors, pre and post shave products, and appliances.

Recommended Stories

Institutional Ownership by Quarter for Procter & Gamble (NYSE:PG)

Should You Invest $1,000 in Procter & Gamble Right Now?

Before you consider Procter & Gamble, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Procter & Gamble wasn't on the list.

While Procter & Gamble currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

(Almost)  Everything You Need To Know About The EV Market Cover

Looking to profit from the electric vehicle mega-trend? Enter your email address and we'll send you our list of which EV stocks show the most long-term potential.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

3 Cheap Growth Stocks Set to Explode This Summer
The Next NVIDIA? Quantum Computing Stocks Set for Explosive Growth
5 Stocks to BUY NOW in July 2025

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines